Detalhe da pesquisa
1.
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study.
Diabetes Obes Metab
; 25(10): 2989-2998, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402696
2.
Effect of a Type 2 Diabetes-Focused Visit Improvement Initiative on Therapeutic Inertia and Glycemic Control in Primary Care.
Clin Diabetes
; 41(2): 296-300, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092139
3.
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes.
Diabet Med
; 39(9): e14901, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708737
4.
Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia.
Diabetes Obes Metab
; 23(11): 2572-2581, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322967
5.
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
JAMA
; 325(14): 1403-1413, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33625476
6.
Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase-4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials.
Diabetes Obes Metab
; 22(4): 658-668, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858673
7.
Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add-on to sodium-glucose co-transporter-2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes.
Diabetes Obes Metab
; 21(6): 1399-1408, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761720
8.
IDegLira improves patient-reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal-bolus therapy.
Diabetes Obes Metab
; 21(12): 2643-2650, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31385425
9.
Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program.
Diabetologia
; 57(3): 485-90, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24317794
10.
Living with Chronic Kidney Disease and Type 2 Diabetes Mellitus: The Patient and Clinician Perspective.
Adv Ther
; 40(1): 1-18, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36282450
11.
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
J Diabetes Sci Technol
; : 19322968221149041, 2023 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36710452
12.
Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study.
Diabetes Ther
; 14(5): 915-924, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905485
13.
Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes.
J Clin Endocrinol Metab
; 109(1): 107-113, 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37560999
14.
A Systematic Review of the use of Precision Diagnostics in Monogenic Diabetes.
medRxiv
; 2023 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131594
15.
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion.
Commun Med (Lond)
; 3(1): 136, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794142
16.
Cancer-associated thrombosis by cancer sites and inherited factors in a prospective population-based cohort.
Thromb Res
; 229: 69-72, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419004
17.
Systematic review of precision subclassification of type 2 diabetes.
medRxiv
; 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131632
18.
Precision subclassification of type 2 diabetes: a systematic review.
Commun Med (Lond)
; 3(1): 138, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37798471
19.
Statistical evidence for high-penetrance MODY-causing genes in a large population-based cohort.
Endocrinol Diabetes Metab
; 5(6): e372, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208030
20.
Leveraging advances in diabetes technologies in primary care: a narrative review.
Ann Med
; 53(1): 805-816, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34184589